Pemphigus vulgaris in pregnancy: Analysis of current data on the management and outcomes

Obstetrical and Gynecological Survey

Volumn 64, Issue 11, 2009, Pages 739-749

  Kardos, Marisa ^a   Levine, Danielle ^a   Gürcan, Hakan M ^b   Ahmed, A Razzaque ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW ENGLAND BAPTIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BACITRACIN; BENZYDAMINE; BETAMETHASONE; BETAMETHASONE VALERATE; CHLORHEXIDINE GLUCONATE; CLOXACILLIN; CORTICOSTEROID; CORTICOTROPIN; CORTISONE; DAPSONE; DICLOXACILLIN; ERYTHROMYCIN; FLUCLOXACILLIN; FLUOCORTOLONE; GENTAMICIN; NYSTATIN; PERMANGANATE POTASSIUM; PREDNISONE; PROPRANOLOL; PSEUDOMONIC ACID; SULFADIAZINE SILVER; TETRACYCLINE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

CYTOMEGALOVIRUS INFECTION; FETUS DEATH; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; LIVE BIRTH; MECONIUM ASPIRATION; NEONATAL PEMPHIGUS; PEMPHIGUS VULGARIS; PLACENTA DISORDER; PLASMAPHERESIS; PNEUMONIA; PREGNANCY; PREGNANCY OUTCOME; REVIEW; STILLBIRTH; UMBILICAL CORD;

ADOLESCENT; ADULT; AZATHIOPRINE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; PEMPHIGUS; PREDNISONE; PREGNANCY; PREGNANCY COMPLICATIONS; STILLBIRTH; YOUNG ADULT;

EID: 70449418122     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3181bea089     Document Type: Review

References (60)

1. Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005;366:61-73.
2. Ahmed AR. Recent advances in the treatment of autoimmune mucocutaneous blistering diseases. Int J Periodontics Restorative Dent 2007;27:309-310.
3. Simon DG, Krutchkoff D, Kaslow RA, et al. Pemphigus in Hartford County, Connecticut, from 1972 to 1977. Arch Der-matol 1980;116:1035-1037.
4. Yeh SW, Sami N, Ahmed RA. Treatment of pemphigus vul-garis: current and emerging options. Am J Clin Dermatol 2005;6:327-342.
5. Shieh S, Fang YV, Becker JL, et al. Pemphigus, pregnancy, and plasmapheresis. Cutis 2004;73:327-329.
6. Ahmed AR, Dahl MV. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol 2003;139:1051-1059.
7. El Tal AK, Posner MR, Spigelman Z, et al. Rituximab: a monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris. J Am Acad Dermatol 2006;55:449-459. (Pubitemid 44189599)
8. Ahmed AR, Spigelman Z, Cavacini LA, et al. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. N Engl J Med 2006;355:1772-1779. (Pubitemid 44631360)
9. Goh MS, McCormack C, Dinh HV, et al. Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients. Br J Dermatol 2007; 156:990-996.
10. Kaplan RP, Callen JP. Pemphigus associated diseases and induced pemphigus. Clin Dermatol 1983;1:42-71.
11. Bonifazi E, Milioto M, Trashlieva V, et al. Neonatal pemphigus vulgaris passively transmitted from a clinically asymptomatic mother. J Am Acad Dermatol 2006;55(suppl 5):S113-S114.
12. Ugajin T, Yahara H, Moriyama Y, et al. Two siblings with neonatal pemphigus vulgaris associated with mild maternal disease. Br J Dermatol 2007;157:192-194.
13. Fenniche S, Benmously R, Marrak H, et al. Neonatal pemphigus vulgaris in an infant born to a mother with pemphigus vulgaris in remission. Pediatr Dermatol 2006;23:124-127.
14. Okubo S, Sato-Matsumura KC, Abe R, et al. The use of ELISA to detect desmoglein antibodies in a pregnant woman and fetus. Arch Dermatol 2003;139:1217-1218.
15. Parlowsky T, Welzel J, Amagai M, et al. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns. J Am Acad Dermatol 2003;48:623-625.
16. Campo-Voegeli A, Muñ iz F, Mascaró JM, et al. Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris. Br J Dermatol 2002;147:801-805.
17. Kalayciyan A, Engin B, Serdaroglu S, et al. A retrospective analysis of patients with pemphigus vulgaris associated with pregnancy. Br J Dermatol 2002;147:396-397.
18. Muhammad JK, Lewis MA, Crean SJ. Oral pemphigus vulgaris occurring during pregnancy. J Oral Pathol Med 2002;31:121-124.
19. Piontek JO, Borberg H, Sollberg S, et al. Severe exacerbation of pemphigus vulgaris in pregnancy: successful treatment with plasma exchange. Br J Dermatol 2000;143:455-456.
20. Fainaru O, Mashiach R, Kupferminc M, et al. Pemphigus vulgaris in pregnancy: a case report and review of literature. Hum Reprod 2000;15:1195-1197. (Pubitemid 30251325)
21. Kanwar AJ, Thami GP. Pemphigus vulgaris and pregnancy-a reappraisal. Aust N Z J Obstet Gynaecol 1999;39:372-373.
22. Hern S, Vaughan Jones SA, Setterfield J, et al. Pemphigus vulgaris in pregnancy with favourable foetal prognosis. Clin Exp Dermatol 1998;23:260-263.
23. Chowdhury MM, Natarajan S. Neonatal pemphigus vulgaris associated with mild oral pemphigus vulgaris in the mother during pregnancy. Br J Dermatol 1998;139:500-503.
24. Ruach M, Ohel G, Rahav D, et al. Pemphigus vulgaris and pregnancy. Obstet Gynecol Surv 1995;50:755-760.
25. Daniel Y, Shenhav M, Botchan A, et al. Pregnancy associated with pemphigus. Br J Obstet Gynaecol 1995;102:667-669.
26. Virgili A, Corazza M, Vesce F, et al. Pemphigus in pregnancy. Acta Dermatol Venereol 1995;75:172-173.
27. Grunwald MH, Zamora E, Avinoach I, et al. Pemphigus neo-natorum. Pediatr Dennatol 1993;10:169-170.
28. Tope WD, Kamino H, Briggaman RA, et al. Neonatal pemphigus vulgaris in a child born to a woman in remission. J Am Acad Dermatol 1993;29:480-485.
29. Kanwar AJ, Dhar S. Pemphigus in pregnancy: fetal risk. Int J Gynaecol Obstet 1993;42:176-177.
30. Goldberg NS, DeFeo C, Kirshenbaum N. Pemphigus vulgaris and pregnancy: risk factors and recommendations. J Am Acad Dermatol 1993;28(5 pt 2):877-879.
31. Okano M, Takijiri C, Aoki T, et al. Pemphigus vulgaris associated with pregnancy: a case report from Japan. Acta Dermatol Venereol 1990;70:517-519.
32. Kanwar AJ, Kaur S, Abraham A, et al. Pemphigus in pregnancy. Am J Obstet Gynecol 1989;161:995-996.
33. Moncada B, Sandoval-Cruz JM, Baranda L, et al. Neonatal pemphigus. Int J Dermatol 1989;28:123-124.
34. Ross MG, Kane B, Frieder R, et al. Pemphigus in pregnancy: a reevaluation of fetal risk. Am J Obstet Gynecol 1986;155: 30-33.
35. Merlob P, Metzker A, Hazaz B, et al. Neonatal pemphigus vulgaris. Pediatrics 1986;78:1102-1105.
36. Hup JM, Bruinsma RA, Boersma ER. Neonatal pemphigus vulgaris: transplacental transmission of antibodies. Pediatr Dermatol 1986;3:468-472.
37. Wasserstrum N, Laros RK Jr. Transplacental transmission of pemphigus. JAMA 1983;249:1480-1482.
38. Green D, Maize JC. Maternal pemphigus vulgaris with in vivo bound antibodies in the stillborn fetus. J Am Acad Dermatol 1982;7:388-392.
39. Storer JS, Galen WK, Nesbitt LT, et al. Neonatal pemphigus vulgaris. J Am Acad Dermatol 1982;6:929-932.
40. Moncada B, Kettelsen S, Hernández-Moctezuma JL, et al. Neonatal pemphigus vulgaris: role of passively transferred pemphigus antibodies. Br J Dermatol 1982;106:465-467.
41. Terpstra H, de Jong MC, Klokke AH. In vivo bound pemphigus antibodies in a stillborn infant. Passive intrauterine transfer of pemphigus vulgaris? Arch Dermatol 1979;115:316-319.
42. Stanoeva L, Konstantinov D, Vć kova M, et al. Association of pemphigus chronicus with pregnancy. Dermatologica 1979; 158:99-103.
43. Ruocco V, Rossi A, Astarita C. A congenital acantholytic bullous eruption in the newborn infant of a pemphigus mother. Ital Gen Rev Dermatol 1975;12:165-174.
44. Wells GC, Ballard RM. Management of pemphigus vulgaris during pregnancy. Proc R Soc Med 1969;62:666-667.
45. McElin TW, Cromer DW. Pemphigus vulgaris complicated by pregnancy. Am J Obstet Gynecol 1965;92:1122-1124.
46. Samitz MH, Greenberg MS, Coletti JM. Pemphigus in association with pregnancy; observations of the effect of corticotropin (ACTH) and cortisone on the pemphigus, the pregnancy, and the infant. AMA Arch Dermatol Syphilol 1953;67:10-17.
47. Gushi M, Yamamoto Y, Mine Y, et al. Neonatal pemphigus vulgaris. J Dermatol 2008;35:529-535.
48. Anhalt GJ. Making sense of antigens and antibodies in pemphigus. J Am Acad Dermatol 1999;40:763-766.
49. Murrell DF, Dick S, Ahmed AR, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 2008;58:1043-1046.
50. Armenti VT, Moritz MJ, Davison JM. Drug safety issue in pregnancy following transplantation and immunosuppression: effects and outcomes. Drug Saf 1998;19:219-232.
51. Ostensen M, Ramsey-Goldman R. Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Drug Saf 1998;19:389-410.
52. Connell W, Miller A. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf 1999;21:311-323.
53. Lehman JS, Mueller KK, Schraith DF. Do safe and effective treatment options exist for patients with active pemphigus vulgaris who plan conception and pregnancy? Arch Dermatol 2008;144:783-785.
54. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005;35: 112-121.
55. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 2000;160:610-619
56. NIH Consensus Development Conference Reports and State of the Science Statements NIH Consensus Development Program-Consensus Development Conference Reports-56. The utility of therapeutic plasmapheresis for neurological disorders. Available at http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat4. section.
57. Harman KE, Gratian MJ, Bhogal BS, et al. A study of desmo-glein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype. Br J Dermatol 2000;143:343-348
58. AAP, Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994 93 137-150.
59. Christensen LA, Dahlerup JF, Nielsen MJ, et al. Azathioprine treatment during lactation. Aliment Pharmacol Ther 2008;28: 1209-1213.
60. Edstein MD, Veenendaal JR, Newman K, et al. Excretion of chloroquine, dapsone and pyrimethamine in human milk. Br J Clin Pharmacol 1986;22:733-735.